Navigation Links
New Research Shows Cadaver Tissue Fails Nearly a Quarter of the Time in Young, Athletic ACL Reconstruction Patients
Date:7/10/2008

Graft Type and Patient Activity Level May Contribute to Failure Rate,

Authors Say

ORLANDO, Fla., July 10 /PRNewswire/ -- With an estimated 80,000 Anterior Cruciate Ligament (ACL) tears happening each year in the United States (Source: American Journal of Sports Medicine 2006 ; 9:1512-1532), including recently to famed golfer, Tiger Woods, choosing the best replacement ligament for surgery is one key to success. A study released today at the 2008 American Orthopaedic Society for Sports Medicine's Annual Meeting at the JW Marriott Orlando Grande Lakes, found that with a failure rate of almost 24 percent, the use of cadaver replacement ligaments may not be the best choice for young, athletic patients.

"Choosing a replacement ligament, whether it comes from a cadaver or the patient's own tissue is a decision that must be made by the surgeon and patient," said co-author Kurre Luber, MD, orthopedic surgery fellow at Mississippi Sports Medicine and Orthopaedic Center. "This study found a very high failure rate in patients 40 years and younger with high activity levels in ACL-dependent sports like tennis, basketball, soccer and downhill skiing. Certainly, it would be naive to think that only the graft selection led to these failures, we also need to look at surgical technique (single versus double bundle). Better outcome measures also need to be developed. However, this study definitely raises questions about the validity of using cadaver tissue in this patient subgroup."

The ACL is one of the major stabilizing ligaments of the knee. Located in the center of the knee joint, it runs from the thigh bone to the shin bone through the center of the knee. Typically, tearing the ACL occurs with a sudden direction change. To repair a torn ACL, a surgeon replaces the damaged ligament with a new one, either from a cadaver or the patient's own body. Typically, either the patellar-tendon bone or the hamstring tendons is used.

In the study, 64 patients, 40 years old or younger with high activity levels who had ACL reconstruction with a cadaver replacement ligament, were followed for a minimum of two years. ACL reconstruction failure was defined as requiring a second reconstruction due to injury or graft failure or poor scores on a combination of orthopaedic outcome measure tests. The study found that 15 (23.4 percent) of the 64 patients' ACL reconstructions failed as defined by the study.

"This failure rate in this young, active population is exceedingly high when compared to a previous study that looked at failure rates of cadaver replacement ligament in patients older than 40," said corresponding author Dr. Gene Barrett. "The older group's failure rate was 2.4 percent. So while there are obvious benefits of using the cadaver ligament, like avoiding a second surgical site on the patient, a quicker return to work and less postoperative pain, for a young patient who is very active, it may not be the right choice."

The American Orthopaedic Society for Sports Medicine (AOSSM) is a world leader in sports medicine education, research, communication and fellowship, and includes national and international orthopaedic sports medicine leaders. The Society works closely with many other sports medicine specialists, including athletic trainers, physical therapists, family physicians, and others to improve the identification, prevention, treatment, and rehabilitation of sports injuries.

For more information, please contact AOSSM Director of Communications Lisa Weisenberger at 847/292-4900, or e-mail her at lisa@aossm.org


'/>"/>
SOURCE American Orthopaedic Society for Sports Medicine
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Researchers design model for automated, wearable artificial kidney
2. New Research Covers Current Trends and Future Directions of the High Performing Pharmaceutical District Sales Managers
3. New Research Shows Cadaver Tissue Fails Nearly a Quarter of the Time in Young, Athletic ACL Reconstruction Patients
4. Cool, Dry Air Blown Under Football Shoulder Pads Reduces Body Temperature and Heart Rate, New Research Finds
5. Cool, air blown under football shoulder pads reduces body temperature and heart rate, research finds
6. NOTES research activities increase with grants from Olympus medical Systems totaling $1 million
7. Researchers Gather to Address New Tools in Development for Breast Cancer Detection
8. Global Industry Analysts' Releases a Series of Medical Market Research Reports
9. UAB joins elite brain cancer research group
10. Lehigh to lead $9.6M national research center for serious behavior disorders
11. Some drugs increase risk of falling: UNC researchers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/25/2017)... ... April 25, 2017 , ... ... committed to raising awareness for Duchenne muscular dystrophy, and funding for Duchenne ... (cardiosphere-derived cells) Phase I/II HOPE clinical trial in Duchenne announced today. , ...
(Date:4/25/2017)... , ... April 25, 2017 , ... ... attempts to compare student test score performance for the 2015-16 school year across ... state’s voucher programs. Though it highlights important patterns in student test score performance, ...
(Date:4/25/2017)... Las Vegas, NV (PRWEB) , ... April 25, ... ... teeth can now choose a modern procedure that achieves results in a fraction ... orthodontist in Las Vegas, NV, with Significance Dental Specialists, now offers this ...
(Date:4/25/2017)... ... , ... Back Pain Centers of America (BPC), which connects people ... their area, announces the launch of a new and proprietary customer relationship management (CRM) ... reputable physicians to help them with back or neck pain and helps to match ...
(Date:4/25/2017)... ... April 25, 2017 , ... ... analytics to its patient care management module. Using this new feature, sleep physicians ... has been initiated on continuous positive airway pressure (CPAP), oral, or other forms ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... Research and Markets has announced the addition of the ... Market and Increasing Usage of Complex Biologics during the Forecast Period" ... ... 20 Billion in 2015 to around USD 26 Billion by 2020. ... by Rapidly Expanding Injectables Market and Increasing Usage of Complex Biologics ...
(Date:4/20/2017)... April 20, 2017  AbbVie (NYSE: ABBV), a ... (n=145/146) of chronic hepatitis C virus (HCV) infected ... 6 and compensated cirrhosis (Child-Pugh A) achieved sustained ... ) with its investigational, pan-genotypic regimen of glecaprevir/pibrentasvir ... seen following 12 weeks of G/P treatment without ...
(Date:4/20/2017)... , April 20, 2017 NeuroVive ... ("NeuroVive") today announced positive preclinical results demonstrating ... compound for non-alcoholic steatohepatitis (NASH), in an ... NV556 has previously shown similar ... model. Today, NeuroVive,s scientists present novel data ...
Breaking Medicine Technology: